In some disease states (e.g., ALS) a significant increase in the expression of inflammatory markers (CD11b and CD68) and inflammatory cytokines (IL‐1β and TNF‐α) was observed in muscle together with degenerative processes in the neuromuscular junctions very early in disease development [37]. The gene discussed is CD68; the disease is amyotrophic lateral sclerosis.